Vinay Prasad takes oversight of vaccines, gene therapies

This week's episode of the Readout LOUD

May 9, 2025 Check out STAT+

Sponsored By

What does the appointment of Vinay Prasad as the head of biologic drug evaluation mean for biotechs? Is his fiery public persona suited for government service? We discuss these and other burning questions on a new episode of "The Readout LOUD," STAT's biotech podcast. Matt Herper joins Adam and Allison to examine Prasad's appointment and the band of outsiders now in charge of U.S. health agencies. He and Adam debate just how disruptive Prasad's tenure could be. Listen Now For more on what Prasad said in his first speech to the Food and Drug Administration staff, go here; for more on Prasad's philosophies on clinical trials and other hot topics, go here; to read STAT's 2017 profile of Prasad, go here; and sign up for Adam's Biotech Scorecard newsletter here. Subscribe to the podcast on Apple Podcasts or Spotify to never miss an episode Visit the archive to see past episodes

---

---

Enjoying The Readout LOUD? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser